TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Voyageur Pharmaceuticals ( (TSE:VM) ) just unveiled an update.
Voyageur Pharmaceuticals has initiated its first commercial shipments of Health Canada-approved barium contrast products to Canadian clinics, marking a significant milestone in its operations. This development is expected to aid in the company’s global expansion efforts and enhance its strategic positioning by leveraging its Frances Creek Project, which offers low-cost production and long-term supply advantages, supporting North American supply chain independence and sustainability goals.
More about Voyageur Pharmaceuticals
Voyageur Pharmaceuticals is a radiology contrast media company focused on vertical integration and supply chain security. The company specializes in barium contrast products for gastrointestinal imaging applications and is working towards expanding its distribution across Canada and potentially into the US market.
Average Trading Volume: 208,569
Technical Sentiment Signal: Buy
Current Market Cap: C$26.08M
For detailed information about VM stock, go to TipRanks’ Stock Analysis page.